Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Goulis

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Hippokratia|June 16, 2023
Severe gastrointestinal cryptosporidiosis three years after multi-visceral transplantationA Tsakona, A Syrnioti, I Goulis, et al.
Hippokratia|August 13, 2013
Treatment of a patient with classical paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome, with complement inhibitor eculizumab: Case ReportE Mandala, C Lafaras, I Goulis, et al.
European Journal of Gastroenterology & Hepatology|April 1, 1997
Tenoxicam-associated hepatic injury: a case report and reviewP Katsinelos, I Katsos, K Patsiaoura, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 26, 2012
Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuationE Cholongitas, T Vasiliadis, N Antoniadis, et al.
Global Health, Epidemiology and Genomics|September 14, 2019
'Distribution of Hepatitis C Virus genotypes in northern Greece in the last decade: descriptive analysis and clinical correlations'G Gioula, E Sinakos, E Gigi, et al.
Hippokratia|December 17, 2009
Hepatitis C and liver transplantationG Tsoulfas, I Goulis, D Giakoustidis, et al.
Journal of Viral Hepatitis|November 12, 2014
Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver diseaseE Cholongitas, T Vasiliadis, I Goulis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 2013
Intermediate hepatocellular carcinoma: current treatments and future perspectivesJ-F Dufour, I Bargellini, N De Maria, et al.
Hippokratia|January 13, 2022
Decreased diversity of salivary microbiome in patients with stable decompensated cirrhosisT Oikonomou, E Cholongitas, G Gioula, et al.
Transplantation Proceedings|March 19, 2019
Trough Levels of Everolimus Are Associated With Recurrence Rates of Hepatocellular Carcinoma After Liver TransplantationE Cholongitas, N Antoniadis, I Goulis, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Hippokratia|June 16, 2023
Severe gastrointestinal cryptosporidiosis three years after multi-visceral transplantationA Tsakona, A Syrnioti, I Goulis, et al.
Hippokratia|August 13, 2013
Treatment of a patient with classical paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome, with complement inhibitor eculizumab: Case ReportE Mandala, C Lafaras, I Goulis, et al.
European Journal of Gastroenterology & Hepatology|April 1, 1997
Tenoxicam-associated hepatic injury: a case report and reviewP Katsinelos, I Katsos, K Patsiaoura, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 26, 2012
Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuationE Cholongitas, T Vasiliadis, N Antoniadis, et al.
Global Health, Epidemiology and Genomics|September 14, 2019
'Distribution of Hepatitis C Virus genotypes in northern Greece in the last decade: descriptive analysis and clinical correlations'G Gioula, E Sinakos, E Gigi, et al.
Hippokratia|December 17, 2009
Hepatitis C and liver transplantationG Tsoulfas, I Goulis, D Giakoustidis, et al.
Journal of Viral Hepatitis|November 12, 2014
Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver diseaseE Cholongitas, T Vasiliadis, I Goulis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 2013
Intermediate hepatocellular carcinoma: current treatments and future perspectivesJ-F Dufour, I Bargellini, N De Maria, et al.
Hippokratia|January 13, 2022
Decreased diversity of salivary microbiome in patients with stable decompensated cirrhosisT Oikonomou, E Cholongitas, G Gioula, et al.
Transplantation Proceedings|March 19, 2019
Trough Levels of Everolimus Are Associated With Recurrence Rates of Hepatocellular Carcinoma After Liver TransplantationE Cholongitas, N Antoniadis, I Goulis, et al.
Pageof 2